Insights into Drug Precipitation Kinetics during In Vitro Digestion of a Lipid-Based Drug Delivery System Using In-Line Raman Spectroscopy and Mathematical Modeling

ABSTRACTPurposeTo determine drug precipitation during in vitro lipolysis of a lipid-based drug delivery system (LBDDS) using Raman spectroscopy as a real-time monitoring technique. A second aim was to describe the kinetics of lipolysis-triggered drug precipitation using a theoretical nucleation and growth model.MethodsA model LBDDS containing different concentration of fenofibrate was digested in vitro and drug precipitation was determined after ultracentrifugation and nanofiltration (off-line methods), as well as by Raman spectroscopy (in-line method). Subsequently, a theoretical nucleation and growth model was fitted to the obtained drug crystallization profiles by considering the lipolysis-triggered change in drug solubility.ResultsCompared with standard off-line measurements, Raman spectroscopy enabled a more robust and highly time-resolved analysis of lipolysis-triggered drug precipitation. Although the formulation was rapidly digested, fenofibrate remained in a supersaturated state for several minutes before beginning to crystallize. The in vitro digestion results were in excellent agreement with the theoretical model (R2 > 0.976).ConclusionsThe combination of real-time Raman spectroscopy and mathematical modeling provided insights into the kinetics of lipolysis-triggered drug crystallization. This knowledge allows a better biopharmaceutical understanding and will, ultimately, lead to the improved development of lipid-based drug formulations.

[1]  P. Geladi,et al.  Linearization and Scatter-Correction for Near-Infrared Reflectance Spectra of Meat , 1985 .

[2]  T. Rades,et al.  Precipitation of a poorly soluble model drug during in vitro lipolysis: characterization and dissolution of the precipitate. , 2010, Journal of pharmaceutical sciences.

[3]  H. Kristensen,et al.  A dynamic in vitro lipolysis model. II: Evaluation of the model. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  A. Hoffman,et al.  Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.

[5]  M. Kuentz,et al.  Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Christopher J H Porter,et al.  Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products , 2002, The Journal of pharmacy and pharmacology.

[7]  Ben J. Boyd,et al.  Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation , 2004, Pharmaceutical Research.

[8]  B. Anderson,et al.  CHEMICAL AND RELATED FACTORS CONTROLLING LIPID SOLUBILITY , 1999 .

[9]  B. Boyd,et al.  Influence of the intermediate digestion phases of common formulation lipids on the absorption of a poorly water-soluble drug. , 2005, Journal of pharmaceutical sciences.

[10]  Dallas B. Warren,et al.  Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[11]  S. Byrn,et al.  Analysis of the Effect of Particle Size on Polymorphic Quantitation by Raman Spectroscopy , 2006, Applied spectroscopy.

[12]  J. Rantanen,et al.  Structural elucidation of rapid solution-mediated phase transitions in pharmaceutical solids using in situ synchrotron SAXS/WAXS. , 2012, Molecular pharmaceutics.

[13]  F. Carrière,et al.  Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems. , 2012, Therapeutic delivery.

[14]  M. Kuentz Lipid-based formulations for oral delivery of lipophilic drugs. , 2012, Drug discovery today. Technologies.

[15]  G. Edwards,et al.  Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. , 2004, Journal of pharmaceutical sciences.

[16]  C. Reppas,et al.  Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers. , 2012, Molecular pharmaceutics.

[17]  Patrick Augustijns,et al.  Excipient-mediated supersaturation stabilization in human intestinal fluids. , 2011, Molecular pharmaceutics.

[18]  B. Griffin,et al.  Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations. , 2008, Advanced drug delivery reviews.

[19]  F. Carrière,et al.  Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. , 2007, Biochimica et biophysica acta.

[20]  C. W. Garner Boronic acid inhibitors of porcine pancreatic lipase. , 1980, The Journal of biological chemistry.

[21]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.

[22]  A. Müllertz,et al.  In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems. , 2011, International journal of pharmaceutics.

[23]  Arik Dahan,et al.  The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. , 2012, Molecular pharmaceutics.

[25]  F. Puel,et al.  In-line monitoring of partial and overall solid concentration during solvent-mediated phase transition using Raman spectroscopy. , 2006, International journal of pharmaceutics.

[26]  P. Annaert,et al.  Drug precipitation-permeation interplay: supersaturation in an absorptive environment. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  R Holm,et al.  Supersaturated Self-Nanoemulsifying Drug Delivery Systems (super-SNEDDS) , 2012 .

[28]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[29]  D. Hauss,et al.  Oral lipid-based formulations : enhancing the bioavailability of poorly water-soluable drugs , 2007 .

[30]  C. Pouton,et al.  Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. , 2009, Journal of pharmaceutical sciences.

[31]  Frans van den Berg,et al.  Review of the most common pre-processing techniques for near-infrared spectra , 2009 .

[32]  J. S. Pedersen,et al.  Structural Development of Self Nano Emulsifying Drug Delivery Systems (SNEDDS) During In Vitro Lipid Digestion Monitored by Small-angle X-ray Scattering , 2007, Pharmaceutical Research.

[33]  A. Hermetter,et al.  Identification of various lipolytic enzymes in crude porcine pancreatic lipase preparations using covalent fluorescent inhibitors , 2004, Biotechnology and bioengineering.

[34]  P. H. Araújo,et al.  Spectroscopic on-line monitoring of reactions in dispersed medium: chemometric challenges. , 2007, Analytica chimica acta.

[35]  J. Patton,et al.  Watching fat digestion. , 1979, Science.

[36]  W. Bensch,et al.  In-situ monitoring of the formation of crystalline solids. , 2011, Angewandte Chemie.

[37]  M. Mazzotti,et al.  Quantitative Application of in Situ ATR-FTIR and Raman Spectroscopy in Crystallization Processes , 2008 .

[38]  Dimo Kashchiev,et al.  Nucleation : basic theory with applications , 2000 .

[39]  A Müllertz,et al.  A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[40]  Lynne S. Taylor,et al.  Crystallization monitoring by Raman spectroscopy: Simultaneous measurement of desupersaturation profile and polymorphic form in flufenamic acid systems , 2005 .

[41]  G. Edwards,et al.  Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs , 2007, Pharmaceutical Research.

[42]  Anette Müllertz,et al.  Colloidal Structures in Media Simulating Intestinal Fed State Conditions with and Without Lipolysis Products , 2009, Pharmaceutical Research.

[43]  Christos Reppas,et al.  Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  G. Edwards,et al.  Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems. , 2012, Molecular pharmaceutics.

[45]  Jean-David Rodier,et al.  Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. , 2008, Biochimica et biophysica acta.

[46]  M. Mazzotti,et al.  In Situ Monitoring and Modeling of the Solvent-Mediated Polymorphic Transformation of l-Glutamic Acid , 2006 .

[47]  F. Mattson,et al.  THE DIGESTION AND ABSORPTION OF TRIGLYCERIDES. , 1964, The Journal of biological chemistry.

[48]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[49]  A. Müllertz,et al.  Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies , 2010, The Journal of pharmacy and pharmacology.

[50]  M. Kuentz,et al.  Comparison of high-resolution ultrasonic resonator technology and Raman spectroscopy as novel process analytical tools for drug quantification in self-emulsifying drug delivery systems. , 2012, Journal of pharmaceutical and biomedical analysis.

[51]  J. H. T. Horst,et al.  Quantitative Measurement of the Polymorphic Transformation of l-Glutamic Acid Using In-Situ Raman Spectroscopy , 2004 .

[52]  Georgios Imanidis,et al.  Advancing in‐vitro drug precipitation testing: new process monitoring tools and a kinetic nucleation and growth model , 2011, The Journal of pharmacy and pharmacology.

[53]  D. Kashchiev,et al.  Review: Nucleation in solutions revisited , 2003 .

[54]  A. Müllertz,et al.  Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity. , 2010, Journal of pharmaceutical sciences.

[55]  B. Boyd,et al.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. , 2003, Journal of pharmaceutical sciences.

[56]  C. Porter,et al.  Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis. , 2001, Journal of pharmaceutical and biomedical analysis.

[57]  R. Barnes,et al.  Standard Normal Variate Transformation and De-Trending of Near-Infrared Diffuse Reflectance Spectra , 1989 .

[58]  Ping Gao,et al.  Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption. , 2009, Journal of pharmaceutical sciences.

[59]  A. Kuksis,et al.  Studies on the substrate specificity of purified human milk lipoprotein lipase , 1982, Lipids.

[60]  G. Edwards,et al.  Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs. , 2008, Journal of pharmaceutical sciences.